Risk Management in Biobanks

  • Sargsyan K
  • Jaksa B
  • Hartl G
  • et al.
N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

The administration of risks is usually an important corner stone of professional operations. Nevertheless, specifically for biobanking organizations, risk recognition , control, management, and easing are inevitably extremely critical elements of everyday operations. The costly kind of unique samples/cell lines, data and also other high-pitched value biobanking products and services such as cell-based drugs, and biologically active pharmaceutical materials call for tremendously precise planning-including the full spectrum of risks. In this chapter, we have included the common risks in biobanking and the management way and methods of risks in a biobanking institution.

Cite

CITATION STYLE

APA

Sargsyan, K., Jaksa, B., Hartl, G., & Macheiner, T. (2020). Risk Management in Biobanks. In Risk Management and Assessment. IntechOpen. https://doi.org/10.5772/intechopen.91463

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free